Keywords
Papillomavirus infections
Cytology
Cone biopsy
Squamous Intraepithelial Lesions of the Cervix
How to Cite
Abstract
High-grade cervical intraepithelial lesion is a precancerous alteration of the squamous epithelium of the cervix, caused by
human papilloma virus. Although homosexual women have factors associated with cervical cancer, it is believed that their
risk is lower, and many do not go for cytology due to negative experiences derived from their sexual orientation, in them,
abnormal cytology and human papilloma virus have been demonstrated in the cervix, but the report of high-grade intrae
pithelial lesion is infrequent. The case of a 31-year-old homosexual woman with abnormal cytology and positive typing for
human papilloma virus is shown. The biopsy reported high-grade cervical intraepithelial lesion confirmed by conization,
negative resection edges. The discovery of a homosexual woman with a high-grade cervical intraepithelial lesion confirms
the importance of including them in screening programs, encouraging their attendance and establishing specific forms of
care based on their condition.
References
Toro Lugo C. Tamización del cáncer de cuello uterino en Colombia: Entendiendo la transición. Curso de Actualización en Ginecología y Obstetricia [Internet]. 2023 [citado 11 de octubre de 2024]. 41-60. Disponible en: https://revistas.udea.edu.co/index.php/ginecologia_y_obstetricia/article/view/346845
Herrero R. Eliminación del cáncer de cérvix en América Latina. Salud Publica Mex [Internet]. 2018;60(6):621-623. Disponible en: https://www.saludpublica.mx/index.php/spm/article/view/10170/11693
Toro-Montoya AI, Tapia-Vela LJ. Virus del papiloma humano (VPH) y cáncer. Med. lab. 2021;25(2):467-83.
Patiño WA, Alvarado A, Guerrero MA, Segovia TY. Detección oportuna del cáncer de cérvix en mujeres en etapa sexual activa. RECIMUNDO. 2018;2(1):645-657.
Massad LS, Xie X, Minkoff H, Darragh TM, D´Souza G, Sanchez-Keeland L, et al. Abnormal Pap tests and human papillomavirus infections among HIV infected and uninfected women who have sex with women. J Low Genit Tract Dis. 2014;18(1):50-56.
Tsikouras P, Zhervoudis S, Manav B, Tomara E, Iatrakis G, Romanidis C, et al. Cervical cancer: screening, diagnosis and staging. J BUON. 2016;21(2):320-325.
Buyukkayaci Duman N, Yildirim F. Gynecological and breast cancer risk factors and screenings in lesbian and bisexual women. Univ Med. 2022;41:184-193.
Roura E, Castellsagué X, Pawlita M, Travier N, Waterboer T, Margall N, et al. Smoking as a major risk factor for cervical cancer and pre-cancer: results from the EPIC cohort. Int. J. Cancer. 2014;135:453-466.
Muñoz N, Bosch FX. The Causal Link between HPV and Cervical Cancer and Its Implications for Prevention of Cervical Cancer. Bull Pan Am Health Organ. 1996;30(4):362-377.
Zur Hausen H. Papillomaviruses in the causation of human cancers - a brief historical account. Virology. 2009;384:260–265.
Alvarez H, Pérez E. Causalidad en Medicina. Gac Méd Méx. 2004; 140(4):467-472.
Castle PE, Maza M. Prophylactic HPV vaccination: past, present, and future. Epidemiol Infect. 2016;144(3):449-468.
Bedell S, Goldstein L, Goldstein AR, Goldstein AT. Cervical Cancer Screening: Past, Present, Future. Sex Med Rev. 2020;8(1):28-37.
Bhatla, N, Singhal S. Primary HPV screening for cervical cancer. Best Practice & Research Clinical Obstetrics and Gynecology. 2020;65:98-108
Gravitt PE, Winer RL. Natural History of HPV Infection across the Lifespan: Role of Viral Latency. Viruses. 2017;9(10):267.
Nayar R, Wilbur DC. The Bethesda System for Reporting Cervical Cytology: A Historical Perspective. Acta cytol. 2017;61(4-5):359-372.
Curmi C, Peters K, Salamonson Y. Lesbians’ attitudes and practices of cervical cancer screening: a qualitative study. BMC Womens Health. 2014;14:153.
Waterman L, Voss J. HPV, cervical cancer risk, and barriers to care for lesbian women. Nurse Pract. 2015;40(1):46-53.
Reiter PL, McRee AL. Cervical cancer screening (pap testing) behaviors and acceptability ofhuman papillomavirus self-testing among lesbian and bisexual women aged 21-26 years in the USA. J Fam Plann Reprod Health Care. 2015;41:259–264.
Compton ML, Taylor SS, Weeks AG, Weiss VL, Hogan MM, Wang H, et al. Cytology and LGBT+ health: establishing inclusive cancer screening programs. J Am Soc Cytopathol. 2022;11(5):241 252.
Ceres M, Quinn GP, Loscalzo M, Rice D. Cancer Screening Considerations and Cancer Screening Uptake for Lesbian, Gay, Bisexual and Transgender Persons. Semin Oncol Nurs. 2018;34(1):37-51.
Solazzo AL, Agénor M, Austin SB, Chavarro JE, Charlton BM. Sexual Orientation Differences in Cervical Cancer Prevention among a Cohort of U.S. Women. Womens Health Issues. 2020;30(4):306–312.
Bailey JV, Kavanagh J, Owen C, McLean KA, Skinner CJ. Lesbians and cervical screening. Br J Gen Pract. 2000;50(455):481-482.
Fethers K, Marks C, Mindel A, Estcourt CS. Sexually transmitted infections and risk behaviours in women who have sex with women. Sex Transm Infect. 2000;76(5):345–349.
Ferris DG, Batish S, Wright TC, Cushing C, Scott EH. A neglected lesbian health concern: cervical neoplasia. J Fam Pract. 1996;43(6):581-584.
O’Hanlan KA, Crum CP. Human papilomavirus associated cervical intraepithelial neoplasia following lesbian 1996;88(4):702-703. sex. Obstet Gynecol.
Terrasa S, Mackintosh R, Piñero A. La atención de pacientes lesbianas, gays y bisexuales y transgénero (primera parte). Evid Act Pract Ambul. 2011;14(2):57-62.
Marrazzo JM, Koutsky LA, Kiviat NB, Kuypers JM, Stine K. Papanicolaou test screening and prevalence of genital human papillomavirus among women who have sex with women. Am J Public Health. 2001;91(6): 947-952.
Saunders CL, Massou E, Waller J, Meads C, Marlow LA, Usher-Smith JA. Cervical screening attendance and cervical cancer risk among women who have sex with women. J Med Screen. 2021;28(3) 349–356. 30. Decreto 762 de 2018. Departamento Administrativo de Función Pública. Diario Oficial No. 50.586, (7 de mayo de 2018). Disponible en: https://www.funcionpublica.gov.co/eva/gestornormativo/norma.php?i=86303
Resolución 3280. Ministerio de Salud y Protección Social. Agosto 2 de 2018. Disponible en: https://www.minsalud.gov.co/Normatividad_Nuevo/Resoluci%C3%B3n%20No.%203280%20de%2020183280.pdf
Henderson H. Why lesbians should be encouraged to have regular cervical screening. J Fam Plann Reprod Health Care. 2009;35(1):49-52.
Poupon C, Poirier M, Blum Y, Lagarrigue S, Parléani C, Vibet MA, et al. Difference in Pap test uptake between women who have sex with women and other women in France: A comparative survey of 2032 women. Prev Med Rep. 2022;30:101990.
Piróg M, Grabski B, Jach R, Zmaczyński A, Dutsch-Wicherek M, Wróbel A, et al. Human Papillomavirus Infection: Knowledge, Risk Perceptions and Behaviors among SMW and AFAB. Diagnostics (Basel). 2022;12(4):843.
Duman NB, Yildirim F. Gynecological and breast cancer risk factors and screenings in lesbian and bisexual women. Univ Med.2022; 41(2):184–193.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2024 Médicas UIS